Tech Company Financing Transactions
Dianosic Funding Round
Bpifrance, Fondation Force and Wiseed invested in a $5 million funding round for Dianosic. The round was announced on 2/6/2023.
Transaction Overview
Company Name
Announced On
2/6/2023
Transaction Type
Venture Equity
Amount
$5,048,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to finance its preclinical in vivo study and launch the phase I clinical trial of its ARIS-R solution for the treatment of chronic allergic rhinitis. In parallel, the company will also continue to develop treatment options for chronic sinusitis (with its ARIS-S solution) and explore other potential applications in the field of ENT. Additionally, the new funding will be used to enhance the technical capability of the team.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
8 place de l'Hôpital
Strasbourg, 67000
FR
Strasbourg, 67000
FR
Phone
Website
Email Address
Overview
Ear Nose and Throat (ENT) conditions are the leading cause of physicians' visits. Yet, there is significant room for improvement to address unmet clinical needs. Dianosic collaborates with healthcare professionals in order to provide solutions that change patients' lives in chronic rhinitis, chronic sinusitis and intranasal bleeding (epistaxis). The company strives for :
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 2/6/2023: Inkle venture capital transaction
Next: 2/6/2023: HowNow venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs